Calyxt gene-edited, heart-healthy soybeans help alleviate America’s biggest soy shortage in years

[Calyxt Inc has] agreed to sell all the gene-edited soybean grains it produced in 2020 to agricultural merchant Archer Daniels Midland Co amid a supply shortage in the United States.

Rising demand from domestic grain processors and lower global stockpiles due to a months-long dry spell in Argentina, has led to an expectation that U.S. soybean ending stocks for the 2020/21 marketing year would be at their lowest level in seven years.

The stocks were seen at 175 million bushels, while analysts were expecting the report to show U.S. soybean stocks of 168 million bushels.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

The food and agriculture biotech company said the sales of about four million bushels of soybean grains, which have zero trans fat per serving and lower saturated fats, began in the third quarter and will continue through late 2021.

ADVERTISEMENT

Calyxt declined to provide an exact deal value, but said it charged a premium to market prices.

Related article:  Ebola reemerges in the eastern Congo, complicating COVID-19 vaccine rollout

Soybean prices were around $11.50 per bushel and the deal would contribute at least $45 million to Calyxt’s revenue, excluding the premium it would charge for the grains, the company said.

As part of the deal, Archer Daniels will crush the grain as well as market and sell the resulting oil and meal.

Calyxt launched the soybean in 2019 as the first commercially approved gene-edited food in the United States.

ADVERTISEMENT
ADVERTISEMENT

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend